Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

The chemokine receptor CCR9 is required for the T-cell-mediated regulation of chronic ileitis in mice.

Wermers JD, McNamee EN, Wurbel MA, Jedlicka P, Rivera-Nieves J.

Gastroenterology. 2011 May;140(5):1526-35.e3. doi: 10.1053/j.gastro.2011.01.044. Epub 2011 Feb 4.

2.

Flt3 ligand expands CD103⁺ dendritic cells and FoxP3⁺ T regulatory cells, and attenuates Crohn's-like murine ileitis.

Collins CB, Aherne CM, McNamee EN, Lebsack MD, Eltzschig H, Jedlicka P, Rivera-Nieves J.

Gut. 2012 Aug;61(8):1154-62. doi: 10.1136/gutjnl-2011-300820. Epub 2011 Nov 7.

3.

Role of beta7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohn's disease.

Apostolaki M, Manoloukos M, Roulis M, Wurbel MA, Müller W, Papadakis KA, Kontoyiannis DL, Malissen B, Kollias G.

Gastroenterology. 2008 Jun;134(7):2025-35. doi: 10.1053/j.gastro.2008.02.085. Epub 2008 Mar 5.

PMID:
18439426
4.

Chemokine receptor CCR7 regulates the intestinal TH1/TH17/Treg balance during Crohn's-like murine ileitis.

McNamee EN, Masterson JC, Veny M, Collins CB, Jedlicka P, Byrne FR, Ng GY, Rivera-Nieves J.

J Leukoc Biol. 2015 Jun;97(6):1011-22. doi: 10.1189/jlb.3HI0614-303R. Epub 2015 Jan 30.

5.

Granulocyte-macrophage colony stimulating factor blockade promotes ccr9(+) lymphocyte expansion in Nod2 deficient mice.

Samson CM, Jurickova I, Molden E, Schreiner W, Colliver J, Bonkowski E, Han X, Trapnell BC, Denson LA.

Inflamm Bowel Dis. 2011 Dec;17(12):2443-55. doi: 10.1002/ibd.21672. Epub 2011 Mar 4.

6.

Antibody blockade of CCL25/CCR9 ameliorates early but not late chronic murine ileitis.

Rivera-Nieves J, Ho J, Bamias G, Ivashkina N, Ley K, Oppermann M, Cominelli F.

Gastroenterology. 2006 Nov;131(5):1518-29. Epub 2006 Aug 16.

PMID:
17101325
7.

CD44 deficiency attenuates chronic murine ileitis.

Collins CB, Ho J, Wilson TE, Wermers JD, Tlaxca JL, Lawrence MB, Solga M, Lannigan J, Rivera-Nieves J.

Gastroenterology. 2008 Dec;135(6):1993-2002. doi: 10.1053/j.gastro.2008.08.053. Epub 2008 Sep 6.

8.

CCL25/CCR9 interactions regulate the function of iNKT cells in oxazolone-induced colitis in mice.

Zhu S, Bing Y, Wang X, Yu Q, Wang Y, Xu S, Song L, Wang X, Xia B, Zhu Y, Zhou R.

PLoS One. 2014 Jun 17;9(6):e100167. doi: 10.1371/journal.pone.0100167. eCollection 2014.

9.

CCL25/CCR9 interactions are not essential for colitis development but are required for innate immune cell protection from chronic experimental murine colitis.

Wurbel MA, Le Bras S, Ibourk M, Pardo M, McIntire MG, Coco D, Geha RS, Fiebiger E, Snapper SB.

Inflamm Bowel Dis. 2014 Jul;20(7):1165-76. doi: 10.1097/MIB.0000000000000059.

PMID:
24874458
10.

CCL25/CCR9 promotes the induction and function of CD103 on intestinal intraepithelial lymphocytes.

Ericsson A, Svensson M, Arya A, Agace WW.

Eur J Immunol. 2004 Oct;34(10):2720-9.

11.

CCR9+ T cells contribute to the resolution of the inflammatory response in a mouse model of intestinal amoebiasis.

Rojas-López AE, Soldevila G, Meza-Pérez S, Dupont G, Ostoa-Saloma P, Wurbel MA, Ventura-Juárez J, Flores-Romo L, García-Zepeda EA.

Immunobiology. 2012 Aug;217(8):795-807. doi: 10.1016/j.imbio.2012.04.005. Epub 2012 May 4.

PMID:
22633147
12.

CCR2 expressing CD4+ T lymphocytes are preferentially recruited to the ileum in Crohn's disease.

Connor SJ, Paraskevopoulos N, Newman R, Cuan N, Hampartzoumian T, Lloyd AR, Grimm MC.

Gut. 2004 Sep;53(9):1287-94. Erratum in: Gut. 2004 Nov;53(11):1722.

13.

Demonstration of functional role of TECK/CCL25 in T lymphocyte-endothelium interaction in inflamed and uninflamed intestinal mucosa.

Hosoe N, Miura S, Watanabe C, Tsuzuki Y, Hokari R, Oyama T, Fujiyama Y, Nagata H, Ishii H.

Am J Physiol Gastrointest Liver Physiol. 2004 Mar;286(3):G458-66. Epub 2003 Oct 30.

PMID:
14592943
14.

CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn's disease.

Papadakis KA, Prehn J, Moreno ST, Cheng L, Kouroumalis EA, Deem R, Breaverman T, Ponath PD, Andrew DP, Green PH, Hodge MR, Binder SW, Targan SR.

Gastroenterology. 2001 Aug;121(2):246-54.

PMID:
11487533
15.

Identification of a chemokine network that recruits FoxP3(+) regulatory T cells into chronically inflamed intestine.

Kang SG, Piniecki RJ, Hogenesch H, Lim HW, Wiebke E, Braun SE, Matsumoto S, Kim CH.

Gastroenterology. 2007 Mar;132(3):966-81. Epub 2007 Jan 5.

PMID:
17324406
16.

Gut-associated lymphoid tissue-primed CD4+ T cells display CCR9-dependent and -independent homing to the small intestine.

Stenstad H, Ericsson A, Johansson-Lindbom B, Svensson M, Marsal J, Mack M, Picarella D, Soler D, Marquez G, Briskin M, Agace WW.

Blood. 2006 May 1;107(9):3447-54. Epub 2006 Jan 3.

17.

Impaired accumulation of antigen-specific CD8 lymphocytes in chemokine CCL25-deficient intestinal epithelium and lamina propria.

Wurbel MA, Malissen M, Guy-Grand D, Malissen B, Campbell JJ.

J Immunol. 2007 Jun 15;178(12):7598-606.

18.

CD4+CD25+ regulatory T cells in the small intestinal lamina propria show an effector/memory phenotype.

Guo Z, Jang MH, Otani K, Bai Z, Umemoto E, Matsumoto M, Nishiyama M, Yamasaki M, Ueha S, Matsushima K, Hirata T, Miyasaka M.

Int Immunol. 2008 Mar;20(3):307-15. doi: 10.1093/intimm/dxm143. Epub 2008 Jan 9.

PMID:
18184698
19.

Semisynthetic diet ameliorates Crohn's disease-like ileitis in TNFΔARE/WT mice through antigen-independent mechanisms of gluten.

Wagner SJ, Schmidt A, Effenberger MJ, Gruber L, Danier J, Haller D.

Inflamm Bowel Dis. 2013 May;19(6):1285-94. doi: 10.1097/MIB.0b013e318281f573.

PMID:
23567784
20.

Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease.

Walters MJ, Wang Y, Lai N, Baumgart T, Zhao BN, Dairaghi DJ, Bekker P, Ertl LS, Penfold ME, Jaen JC, Keshav S, Wendt E, Pennell A, Ungashe S, Wei Z, Wright JJ, Schall TJ.

J Pharmacol Exp Ther. 2010 Oct;335(1):61-9. doi: 10.1124/jpet.110.169714. Epub 2010 Jul 21.

Supplemental Content

Support Center